BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

Germline mutations in the BRCA1 or BRCA2 genes are associated with an increased risk of breast and ovarian cancer development. Both genes are involved in DNA repair, and tumors harboring genetic defects in them are thought to be more sensitive to DNA-damaging agents used in chemotherapy. However, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefansson, Olafur A., Villanueva, Alberto, Vidal, August, Martí, Lola, Esteller, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499323/
https://www.ncbi.nlm.nih.gov/pubmed/23069641
http://dx.doi.org/10.4161/epi.22561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499323/
https://www.ncbi.nlm.nih.gov/pubmed/23069641
http://dx.doi.org/10.4161/epi.22561

Ejemplares similares